239 related articles for article (PubMed ID: 10857534)
1. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
Liu S; Tunkel R; Lachmann E; Nagler W
Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
Lin JT; Lachmann E; Nagler W
J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
Saeed DB; Gupta L
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
6. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
Santillan A; Bristow RE
Nat Clin Pract Oncol; 2006 Feb; 3(2):108-12; quiz 1 p following 112. PubMed ID: 16462852
[TBL] [Abstract][Full Text] [Related]
8. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
Key RG; Root JC
Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.
Bradley WH; Dottino PR; Rahaman J
Int J Gynecol Cancer; 2008; 18(6):1364-7. PubMed ID: 18217973
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
Bruhnding A; Notch D; Beard A
J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
[TBL] [Abstract][Full Text] [Related]
16. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
17. Rehabilitation treatment options for a patient with paraneoplastic cerebellar degeneration.
Perlmutter E; Gregory PC
Am J Phys Med Rehabil; 2003 Feb; 82(2):158-62. PubMed ID: 12544763
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic cerebellar degeneration: neurological symptoms pointing to occult ovarian cancer.
Geomini PM; Dellemijn PL; Bremer GL
Gynecol Obstet Invest; 2001; 52(2):145-6. PubMed ID: 11586046
[TBL] [Abstract][Full Text] [Related]
19. Anti-Yo paraneoplastic cerebellar degeneration in a patient with stage IV ovarian adenocarcinoma during bevacizumab maintenance therapy.
Giucca A; Morrison H; Wilson T; Cossburn M
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37137547
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer: PCD and brain metastases.
Stepanić V; Matković V; Corusić A; Barisić D; Buković D; Ilić-Forko J
Coll Antropol; 2007 Jun; 31(2):633-6. PubMed ID: 17847951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
